Possible conflicts of interest

Potential conflicts of interests (Danske og internationale samarbejdspartnere)

• Munksgaard (publisher): Susanne Dam Poulsen is author and editor of MK20.
• 2023-2024 Susanne Dam Poulsen has served on advisory boards for Gilead, GSK, and Takeda.

Research funds (Bestyrelsesposter)

• None

Research funding obtained from (Midler)

• The COCOMO study was supported by Rigshospitalet Research Fund, Svend Andersen Fonden, Lundbeck Fonden, Augustinus Fonden, Skibsreder Per Henriksen, R. og hustrus fond, Åse og Ejnar Danielsens Fond, Region Hovedstaden, and an unrestricted grant from Gilead.
• The DACOLT study was supported by Rigshospitalet Research Fund, Svend Andersen Fonden, Kirsten og Freddy Johansens Fond, Arvid Nilssons Fond, and Københavns Medicinske Selskab.
• The HINT/HISTORY study was supported by the Novo Nordic Foundation, Regionernes Medicin- og Behandlingspulje, and Augustinus Fonden.
• COVID-19 vaccination studies, including REACT, was supported by the European Union funding program for research and innovation for the Horizon 2020, Rigshospitalet Research Fund, Åse og Ejnar Danielsens Fond, Augustinus Fonden, Læge Sofus Carl Emil Friis og Hustru Olga Friis’ Legat.

Travel grants (I forbindelse med møder/konferencer)

• 2023-2024 Gilead
• Previous speaker Gilead, Takeda, GSK